T-cell-targeted peptide epitope vaccine (Francisella tularensis infection) (Emergex)

N/A

Report date: 2025/01/26 16:06:32

Base Information

Drug NameT-cell-targeted peptide epitope vaccine (Francisella tularensis infection) (Emergex)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant polypeptideVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsTularemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGylden Pharma Ltd

China Registration ClassN/A

Develop Information

Active CompaniesGylden Pharma Ltd

Inactive CompaniesN/A

Active IndicationsTularemia

Inactive IndicationsN/A

Other Information

ATC CodeN/A